These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis. Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320 [TBL] [Abstract][Full Text] [Related]
3. [New orientations in the management of advanced, metastatic gastrointestinal stromal tumors (GIST): combination of surgery and systemic therapy with imatinib in a case of primary gastric location]. Catani M; De Milito R; Simi M Chir Ital; 2005; 57(1):127-33. PubMed ID: 15832750 [TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: A clinicopathologic study of 8 cases. Herawi M; Montgomery EA; Epstein JI Am J Surg Pathol; 2006 Nov; 30(11):1389-95. PubMed ID: 17063078 [TBL] [Abstract][Full Text] [Related]
5. [Gastrointestinal stromal tumor (GIST)--medical rarities?]. Predescu D; Gheorghe M; Predoiu I; Iosif C; Constantin A; Chiru F; Cociu L; Constantinoiu S Chirurgia (Bucur); 2010; 105(4):577-85. PubMed ID: 20941986 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases]. Garrido S M; Moneada M M; Tapia N G; Méndez O G; Galindo A H; Huete G A; Ibáñez A L; González S; Alvarez Z M Rev Med Chil; 2007 Oct; 135(10):1327-32. PubMed ID: 18180842 [TBL] [Abstract][Full Text] [Related]
7. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors. Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300 [TBL] [Abstract][Full Text] [Related]
8. [Successful resection of an advanced gastrointestinal stromal tumor by neoadjuvant chemotherapy with imatinib- a case report]. Nakajima S; Sonoda K; Kadokawa Y; Kawabe A; Yamamoto T Gan To Kagaku Ryoho; 2009 Dec; 36(13):2645-8. PubMed ID: 20009472 [TBL] [Abstract][Full Text] [Related]
9. Outcome of metastatic GIST in the era before tyrosine kinase inhibitors. Gold JS; van der Zwan SM; Gönen M; Maki RG; Singer S; Brennan MF; Antonescu CR; De Matteo RP Ann Surg Oncol; 2007 Jan; 14(1):134-42. PubMed ID: 17080234 [TBL] [Abstract][Full Text] [Related]
11. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression. Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121 [TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of 60 cases with malignant gastrointestinal stromal tumors]. Lin F; Cao J; Xia JT; Huang CM; DU H; Chen GQ; Wen MJ; Dai LH; Lai YY Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):409-11. PubMed ID: 17043962 [TBL] [Abstract][Full Text] [Related]
13. Gastric GISTs. Personal experience. Mingolla GP; Riccio PA; Linguerri R; La Donna M; Zannelli M; Artuso S Ann Ital Chir; 2007; 78(4):283-8; discussion 288-9. PubMed ID: 17990602 [TBL] [Abstract][Full Text] [Related]
14. [Two cases of gastrointestinal stromal tumor (GIST) of the stomach and a consideration of its malignancy potential and treatment strategy - report of two cases]. Asakage N; Kobayashi S; Gotou T; Sasaki M; Tsukada K; Suzuki T; Yamamoto T; Sekine M; Miyazaki E; Hirai S; Yamasaki S Gan To Kagaku Ryoho; 2007 Jun; 34(6):919-23. PubMed ID: 17565257 [TBL] [Abstract][Full Text] [Related]
15. The neo-adjuvant treatment in gastrointestinal stromal tumor. Catania V; Consoli A; Cavallaro A; Liardo RL; Malaguarnera M Eur Rev Med Pharmacol Sci; 2010 Aug; 14(8):727-30. PubMed ID: 20707293 [TBL] [Abstract][Full Text] [Related]
17. Imatinib mesylate treatment for advanced gastrointestinal stromal tumor: a pilot study focusing on patients experiencing sole liver metastasis after a prior radical resection. Zhu J; Wang Y; Hou M; Li HY; Zhang J Oncology; 2007; 73(5-6):324-7. PubMed ID: 18497504 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of gastrointestinal stromal tumor (GIST)--review of the literature and a case report]. Geraci G; Li Volsi F; Pisello F; Sciumè C; Cajozzo M; Cavaleri C; Modica G Ann Ital Chir; 2005; 76(4):377-80; discussion 381. PubMed ID: 16550875 [TBL] [Abstract][Full Text] [Related]
20. Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate. McAuliffe JC; Lazar AJ; Yang D; Steinert DM; Qiao W; Thall PF; Raymond AK; Benjamin RS; Trent JC Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6727-34. PubMed ID: 18006774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]